methyl 3-[(4'R)-N-tert-butoxycarbonyl-2',2'-dimethyloxazolidin-4'-yl]propenoate | 183253-75-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: methyl 3-[(4'R)-N-tert-butoxycarbonyl-2',2'-dimethyloxazolidin-4'-yl]propenoate
• CAS: 183253-75-0
• 化学式: C₁₄H₂₃NO₅
• 分子量: 285.34
• InChiKey: YSNYRLFAMVTFTM-SNVBAGLBSA-N

物化性质

• 沸点：
  368.4±42.0 °C(Predicted)
• 密度：
  1.130±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.09
• 重原子数：
  20.0
• 可旋转键数：
  2.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  65.07
• 氢给体数：
  0.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  methyl 3-[(4'R)-N-tert-butoxycarbonyl-2',2'-dimethyloxazolidin-4'-yl]propenoate 在 三氟化硼乙醚 、 二异丁基氢化铝 、 间氯过氧苯甲酸 作用下， 以 二氯甲烷 为溶剂， 反应 17.0h， 生成 (4S,1'R,2'S)-3-(N-tert-butoxycarbonyl)-4-(3-hydroxy-1,2-epoxy-propan-1-yl)-2,2-dimethyl-1,3-oxazolidine
  参考文献：
  名称：

  Total synthesis of galantin I. Acid-catalyzed cyclization of galantinic acid

  摘要：

  The proposed structure of galantin 1, a peptide antibiotic isolated from Bacillus pulvifaciens as a mixture of congeners (1a with the D-ornithine residue and lb with D-lysine; 1a/1b = 9/1), was shown to be incorrect by total synthesis. The substructure 3a, named galantinic acid, was an artifact, and its correct structure was assumed to be the hydroxylated form, 20a or 20b, by spectroscopic comparisons of synthetic la with natural galantin I. The synthesis of both diastereomers, 4a and 4b, again suggested that the sequence of the spermidine moiety of galantin I should be N5,N8. Finally, the correct structure of galantin I as 5a was confirmed by the synthesis of diastereomers 5a and 5b. The synthesis of 5a was accomplished in a convergent manner by the coupling of the protected forms of the constituent amino acids: D-ornithine, 6b, D-alanine, 23b, 11b, 8c, and 19a. Galantinic acid residue 20a, present in natural galantin 1, was found to undergo cyclization with retention of its C3 configuration under the chemical degradation conditions to give the artifact 3a. In order to elucidate the mode of cyclization of 20a to 3a, the synthesis of 20a and its analogues was accomplished in a stereoselective manner from D-serine. The synthesis was characterized by the stereoselective epoxidation of hydroxymethyl (Z)-allylamine 34 and alpha,beta-unsaturated delta-lactone 39. Acidolysis of 20a, 20b, and their analogues suggested that the stereoselective cyclization of galantinic acid was initiated by the formation of delta-lactone 54, which through the sequence of reactions should afford the artifact 3a.

  DOI：

  10.1021/ja00029a031
• 作为产物：
  描述：

  3-反-溴碳-2,2'-二甲基氧酸酯 、 甲氧羰基亚甲基三苯基正膦 以 苯 为溶剂， 以95%的产率得到methyl 3-[(4'R)-N-tert-butoxycarbonyl-2',2'-dimethyloxazolidin-4'-yl]propenoate
  参考文献：
  名称：

  Revisiting the Kinnel–Scheuer hypothesis for the biosynthesis of palau'amine

  摘要：

  在此，我们提出了帕劳胺的另一种生物合成途径，以解决最初的 KinnelâScheuer 假设中的立体化学问题。此外，我们还将这一修正后的假说作为实验室合成帕劳胺的指南。

  DOI：

  10.1039/c0cc02214d

文献信息

• [EN] CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF BACKGROUND<br/>[FR] MODULATEURS DE CALPAIN ET LEURS UTILISATIONS THÉRAPEUTIQUES
  申请人：BLADE THERAPEUTICS INC

  公开号：WO2019217465A1

  公开（公告）日：2019-11-14

  Disclosed herein are small molecule calpain modulators, pharmaceutical compositions, preparation methods and their use as therapeutic agents. The therapeutic agents can be used for treating fibrotic disease or a resulting secondary disease state or condition. The small molecules can inhibit calpain through contact with CAPN1, CAPN2, and/or CAPN9 enzymes.

  本文披露了小分子钙蛋白酶调节剂、药物组合物、制备方法以及它们作为治疗剂的用途。这些治疗剂可用于治疗纤维化疾病或由此引起的继发性疾病状态或症状。这些小分子可以通过与CAPN1、CAPN2和/或CAPN9酶接触来抑制钙蛋白酶。
• Revisiting the Kinnel–Scheuer hypothesis for the biosynthesis of palau'amine
  作者：Zhiqiang Ma、Jianming Lu、Xiao Wang、Chuo Chen

  DOI：10.1039/c0cc02214d

  日期：——

  We propose herein an alternative biosynthetic pathway for palau'amine in order to resolve the stereochemical issue from the original Kinnel–Scheuer hypothesis. Furthermore, we use this revised hypothesis as a guide toward the laboratory synthesis of palau'amine.

  在此，我们提出了帕劳胺的另一种生物合成途径，以解决最初的 KinnelâScheuer 假设中的立体化学问题。此外，我们还将这一修正后的假说作为实验室合成帕劳胺的指南。
• Rhodium-Catalyzed Cyclohydrocarbonylation Approach to the Syntheses of Enantiopure Homokainoids
  作者：Wen-Hua Chiou、Angèle Schoenfelder、Liang Sun、André Mann、Iwao Ojima

  DOI：10.1021/jo070942n

  日期：2007.12.1

  homokainoids in an enantiomerically pure form were synthesized from enantiopure (R)- and (S)-Garner's aldehyde, featuring (i) the highly diastereoselective addition of alkenylcuprates to the acrylate intermediates and (ii) the Rh-catalyzed cyclohydrocarbonylation of homoallylic amine intermediates to construct the functionalized piperidine moiety in the key steps. For the introduction of a substituent at the 4-

  海藻酸的同系物是一种天然存在的强效谷氨酸受体激动剂，它是基于硬化的胡椒基谷氨酸结构设计的，由于其在中枢神经系统中的潜在活性，因此可以被视为同型类胡萝卜素。这些对映体纯净形式的新类化合物均由对映体（R）和（S）合成。）-加纳醛，其特征是（i）在丙烯酸酯中间体上高度非对映选择性地加成烯基铜酸酯，以及（ii）在关键步骤中Rh催化均烯丙基胺中间体的环氢羰基化反应以构建官能化的哌啶部分。为了在胡椒基谷氨酸的4位或5位引入取代基，使用了几种不同的策略，这些策略成功地导致了对映纯同型类化合物的形成。
• Stereoselective Total Synthesis of (+)-Valienamine and (+)-4-<i>epi</i>-Valienamine via a Ring-Closing Enyne Metathesis Protocol
  作者：Palakodety Radha Krishna、P. Srinivas Reddy

  DOI：10.1055/s-0028-1087669

  日期：——

  Stereoselective total synthesis of (+)-valienamine is reported utilizing Sharpless asymmetric dihydroxylation, diastereoselective Carreira alkynylation, and ring-closing enyne metathesis (RCEYM) as key steps from l-serine. A similar strategy is also reported for the first total synthesis of (+)-4-epi-valienamine.

  据报道，利用Sharpless不对称二羟基化、非对映选择性Carreira炔基化以及环闭合烯炔复分解（RCEYM）作为从l-丝氨酸合成(+)-valienamine的关键步骤，实现了(+)-valienamine的立体选择性全合成。据报道，类似的策略也用于首次全合成(+)-4-epi-valienamine。
• Total synthesis of galantin I. Acid-catalyzed cyclization of galantinic acid
  作者：Naomi Sakai、Yasufumi Ohfune

  DOI：10.1021/ja00029a031

  日期：1992.1

  The proposed structure of galantin 1, a peptide antibiotic isolated from Bacillus pulvifaciens as a mixture of congeners (1a with the D-ornithine residue and lb with D-lysine; 1a/1b = 9/1), was shown to be incorrect by total synthesis. The substructure 3a, named galantinic acid, was an artifact, and its correct structure was assumed to be the hydroxylated form, 20a or 20b, by spectroscopic comparisons of synthetic la with natural galantin I. The synthesis of both diastereomers, 4a and 4b, again suggested that the sequence of the spermidine moiety of galantin I should be N5,N8. Finally, the correct structure of galantin I as 5a was confirmed by the synthesis of diastereomers 5a and 5b. The synthesis of 5a was accomplished in a convergent manner by the coupling of the protected forms of the constituent amino acids: D-ornithine, 6b, D-alanine, 23b, 11b, 8c, and 19a. Galantinic acid residue 20a, present in natural galantin 1, was found to undergo cyclization with retention of its C3 configuration under the chemical degradation conditions to give the artifact 3a. In order to elucidate the mode of cyclization of 20a to 3a, the synthesis of 20a and its analogues was accomplished in a stereoselective manner from D-serine. The synthesis was characterized by the stereoselective epoxidation of hydroxymethyl (Z)-allylamine 34 and alpha,beta-unsaturated delta-lactone 39. Acidolysis of 20a, 20b, and their analogues suggested that the stereoselective cyclization of galantinic acid was initiated by the formation of delta-lactone 54, which through the sequence of reactions should afford the artifact 3a.